Fluent

Fluent Long-term Debt

Delisted

The Long-Term Debt of Fluent (TIUM.U.CN) as of Nov 6, 2026 is 98.43 M USD. In the previous year, Long-Term Debt was 90.89 M USD — a change of 8.30% (higher).

Long-term Debt

98.43 MUSD

YoY

8.30%

Last updated:

Long-Term Debt of Fluent is 2023 98.43 M USD. Long-Term Debt of Fluent was 2022 90.89 M USD. It decreases by 8.30% higher compared to the previous year.

The Fluent Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2019
52.22 M USD
Jan 1, 2020
33.99 M USD
Jan 1, 2021
74.77 M USD
Jan 1, 2022
90.89 M USD
Jan 1, 2023
98.43 M USD
The Fluent Long-term Debt history
YEARLong-term DebtYoY
98.43 MUSD+8.30%
90.89 MUSD+21.57%
74.77 MUSD+119.94%
33.99 MUSD-34.90%
52.22 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Long-Term Debt of Fluent is 98.43 M USD in 2023.

Long-Term Debt of Fluent changed from 90.89 M USD to 98.43 M USD, representing a 8.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Fluent since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Fluent historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Fluent

All Key Metrics — Fluent